The current limitations of surgical treatment, as well as restrictions on professional and sport activities related to COVID-19
pandemic require seeking therapeutic solutions for the vast population of patients with chronic venous insufficiency (CVI,
chronic venous insufficiency). To understand the principles of pharmacotherapy of this disease, the authors used data related
to epidemiology and pathophysiology of CVI. They provided the latest data on venoactive drugs and recommendations that
should be followed and summarized the literature based on the EBM. The article should provide the answer to the question
of how to deal with patients with varicose veins or, more broadly, chronic venous insufficiency during the pandemic.
Artykuł jest dostępny na zasadzie dozwolonego użytku osobistego. Dalsze rozpowszechnianie (w tym druk i umieszczanie w sieci) jest zabronione i stanowi poważne naruszenie przepisów prawa autorskiego oraz grozi sankcjami prawnymi.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.